Cardiac events and dynamic echocardiographic and electrocardiogram changes following osimertinib treatment in lung cancer

Cardiac events and dynamic echocardiographic and electrocardiogram changes following osimertinib treatment in lung cancer

Osimertinib is first-line treatment for epidermal growth factor (EGFR)-mutated non-small cell lung cancer (NSCLC) and has been associated with cardiotoxicity. However, the nature of cardiac remodeling and associated risk factors remains incompletely understood. Retrospective analysis of NSCLC patien...

Mô tả đầy đủ

Chi tiết về thư mục
Những tác giả chính: Jonathan N. Le, Jordan O. Gasho, Olivia Peony, Asneh Singh, Katrina D. Silos, Sungjin Kim, Anthony T. Nguyen, Mitchell Kamrava, Amin Mirhadi, Behrooz Hakimian, Karen L. Reckamp, Kamya Sankar, Raymond H. Mak, Andriana P. Nikolova, Katelyn M. Atkins
Định dạng: Bài viết
Ngôn ngữ:English
Được phát hành: Frontiers Media S.A. 2024-12-01
Loạt:Frontiers in Cardiovascular Medicine
Những chủ đề:
osimertinib
lung cancer
cardiac toxicity
echocardiogram
EGFR
Truy cập trực tuyến:https://www.frontiersin.org/articles/10.3389/fcvm.2024.1485033/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2024.1485033/full

Những quyển sách tương tự